Stuart Ray

864 total citations
5 papers, 197 citations indexed

About

Stuart Ray is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Stuart Ray has authored 5 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Pharmacology. Recurrent topics in Stuart Ray's work include Signaling Pathways in Disease (2 papers), Peptidase Inhibition and Analysis (2 papers) and Down syndrome and intellectual disability research (1 paper). Stuart Ray is often cited by papers focused on Signaling Pathways in Disease (2 papers), Peptidase Inhibition and Analysis (2 papers) and Down syndrome and intellectual disability research (1 paper). Stuart Ray collaborates with scholars based in United Kingdom, Denmark and Italy. Stuart Ray's co-authors include P. Dokurno, A.E. Surgenor, James B. Murray, Lisa Baker, Chris Bryant, Christine M. Richardson, Jonathan D. Moore, Andrew Potter, Ben Davis and David A. Robinson and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecular Cancer Therapeutics and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Stuart Ray

5 papers receiving 189 citations

Peers

Stuart Ray
A. Amos United Kingdom
Frederick A. Brookfield United Kingdom
Marcel Scheepstra Netherlands
Geoffrey J. Cutler United Kingdom
Tadashi Terasaka Japan
Simeon Bowers United States
Christine Fernandes United States
Emma J. Jones United Kingdom
Melissa A. Liriano United States
Lawrence Andrade United States
A. Amos United Kingdom
Stuart Ray
Citations per year, relative to Stuart Ray Stuart Ray (= 1×) peers A. Amos

Countries citing papers authored by Stuart Ray

Since Specialization
Citations

This map shows the geographic impact of Stuart Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Ray more than expected).

Fields of papers citing papers by Stuart Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Ray. The network helps show where Stuart Ray may publish in the future.

Co-authorship network of co-authors of Stuart Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Ray. A scholar is included among the top collaborators of Stuart Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Ray. Stuart Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Williamson, D.S., Garrick P. Smith, Lassina Badolo, et al.. (2021). Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. Journal of Medicinal Chemistry. 64(14). 10312–10332. 23 indexed citations
2.
Walmsley, Lee, James B. Murray, P. Dokurno, et al.. (2021). Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B. Journal of Medicinal Chemistry. 64(13). 8971–8991. 31 indexed citations
3.
Potter, Andrew, Christophe Fromont, Stuart Ray, et al.. (2010). Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution. Bioorganic & Medicinal Chemistry Letters. 20(22). 6483–6488. 69 indexed citations
4.
Potter, Andrew, Stuart Ray, Chris Bryant, et al.. (2009). Structure-guided design of α-amino acid-derived Pin1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(2). 586–590. 73 indexed citations
5.
Massey, Andrew J., S.P. Stokes, Helen Browne, et al.. (2009). Abstract C207: Checkpoint abrogation and potentiation of cytotoxic chemotherapeutics with a novel checkpoint kinase 1 inhibitor. Molecular Cancer Therapeutics. 8(12_Supplement). C207–C207. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Amos Breakdown of academic impact, for papers by Frederick A. Brookfield Breakdown of academic impact, for papers by Marcel Scheepstra Breakdown of academic impact, for papers by Geoffrey J. Cutler Breakdown of academic impact, for papers by Tadashi Terasaka Breakdown of academic impact, for papers by Simeon Bowers Breakdown of academic impact, for papers by Christine Fernandes Breakdown of academic impact, for papers by Emma J. Jones Breakdown of academic impact, for papers by Melissa A. Liriano Breakdown of academic impact, for papers by Lawrence Andrade
Rankless by CCL
2026